Detaylı Özgeçmişe Buradan Ulaşabilirsiniz.

Detaylı Özgeçmişe Buradan Ulaşabilirsiniz.

ESİN TUNA
Cep: 0531 372 44 53
E-mail: [email protected] / [email protected]
İŞ DENEYİMİ

16.12.2013 – …: Polar Sağlık Ekonomisi ve Politikası Danışmanlık (Ankara)
Sağlık Ekonomisi ve Politikası Uzmanı

08.10.2012 – 06.12.2013: Bayer (Ankara)
Sağlık Politikası Uzmanı (Pazar Erişim Departmanı)
EĞİTİM DURUMU

2014-…..: Hacettepe Üniversitesi Sosyal Bilimler Fakültesi, Sağlık Ekonomisi ve
Farmakoekonomi Programı, Yüksek Lisans Öğrencisi

2011-… : Hacettepe Üniversitesi Eczacılık Fakültesi, Biyofarmasötik ve Farmakokinetik Bilim
Dalı/ Farmasötik Teknoloji Anabilim Dalı, Yüksek Lisans Öğrencisi

2011-2006: Hacettepe Üniversitesi, Eczacılık Fakültesi

Erasmus
La Faculté des Sciences Pharmaceutiques et Biologiques de Lille 08.09.2008 - 26.06.2009

2006-2003: Ankara Atatürk Anadolu Lisesi

2003-1998: TED Ankara Koleji
STAJLAR

24.04.2012-11.05.2012 İlko Argem (Ankara)
Ar-Ge Departmanı (Gönüllü staj)

06.2011-09.2011 İlaç Eczacılık Genel Müdürlüğü (Ankara)
Farmakoekonomi Departmanı (Gönüllü staj)
1

02.2011-05.2011 Sibel Ersoy Eczanesi (Ankara)
(Staj)

06.2010-07.2010 Fresenius Medical Care (İstanbul)
Ruhsatlandırma Departmanı (Staj)

08.2009-09.2009 Sibel Ersoy Eczanesi (Ankara)
(Staj)

11.2008-06.2009 Pharmacie du Faubourg (Fransa)
Stajyer Eczacı (Gönüllü staj)
SERTİFİKALAR

Elements of Pharmaceutical / Biotech Pricing Short Course – ISPOR 17th Annual
European Congress – 11.2014 (Amsterdam, Hollanda)

Risk-sharing/Performance-based Arrangements for Drugs and Other Medical Products
Short Course – ISPOR 17th Annual European Congress – 11.2014 (Amsterdam, Hollanda)

Discrete Event Simulation for Economic Analyses Short Course – ISPOR 17th Annual
European Congress – 11.2014 (Amsterdam, Hollanda)

Reimbursement Systems for Pharmaceuticals in Europe Short Course – ISPOR 17th
Annual European Congress – 11.2014 (Amsterdam, Hollanda)

Olağanüstü Verimlilik için 5 Seçim Eğitimi – Franklin Covey – 11.2013 (İstanbul)

Advocacy Eğitimi – Bayer – 04.2013 (İstanbul)

Sağlık Ekonomisi Eğitimi – Bayer – 04.2013 (İstanbul)

Sunum Teknikleri Eğitimi – İzgören Akademi – 27.10.2011 (Ankara)

18. Uluslararası Mikroenkapsülasyon Sempozyumu – 14.09.2011 (Antalya)

International Symposium on Drug Research & Development 'From Chemistry to
Medicine' DRD 2011 – MAGUM – 29.05.2011 (Antalya)

34. EPSA Yıllık Kongresi – 15.04.2011 (Lizbon/PORTEKİZ)

Life Long Learning Certificate – 15.04.2011
2

23rd Annual Euromeeting of DIA – 30.03.2011 (Cenevre/İSVİÇRE)

7. EPSA Sonbahar Kongresi- Katılım Sertifikası (Helsinki/FİNLANDİYA)
EPSA (European Pharmaceutical Students Association) - 30.10.2010

Her Yönüyle Eczacılık Sempozyumu – Anadolu Üniversitesi – 23.05.2010 (Eskişehir)

33. EPSA Yıllık Kongresi- Katılım Sertifikası (Krakow/POLONYA)
EPSA - 02.05.2010
SINAV BİLGİLERİ

TOEFL-IBT (Test of English as a Foreign Language - Internet based test) (95)
o

ETS - 2012
KPDS (Kamu Personeli Dil Sınavı) (87.5)
OSYM - 2011

ALES (Akademik Personel ve Lisansüstü Eğitimi Giriş Sınavı) (96.2)
OSYM - 2010
YABANCI DİL
İngilizce: İleri seviyede
Fransızca: Başlangıç seviyesi
BİLGİSAYAR
MS Office programları; Windows, Word, Powerpoint, Excel
PROJELER
15.10.2012-22.10.2012 ‘Antibiyotikler Şeker Değildir’ adlı Avrupa Birliği Projesi’nin yazımı ve
koordinatörlüğü
01.10.2011-08.10.2011 ‘Kanserde Erken Teşhis Hayat Kurtarır’ adlı Avrupa Birliği Projesi’nin yazımı ve
koordinatörlüğü
3
MAKALE ve POSTERLER
Makale:
1.
Results of Reference Pricing and Reimbursement Discount Rate Schemes of Turkey
ISPOR Value in Health – Vol 14 No 2
Posterler:
1. Comparing Cost of Therapeutic Plasma Exchange and Intravenous Immunoglobulin
Infusion in Treating Guillain-Barre Syndrome
ISPOR 15th Annual European Congress (3-7 Kasım 2012) - Berlin/ ALMANYA
2. Possible Budget Impact of Internal Reference Pricing for Statins in Turkey
ISPOR 15th Annual European Congress (3-7 Kasım 2012) - Berlin/ ALMANYA
3. Net Tax Revenue with a National Based Rotavirus Vaccination Program in Turkey
ISPOR 15th Annual European Congress (3-7 Kasım 2012) -Berlin/ ALMANYA
4. The Cost-of-Disease of Thromboembolic and Hemorrhagic Complications Associated with
Atrial Fibrillation and its Treatment in Turkey: An Expert Panel Approach for Estimation
of Costs
ISPOR 18th Annual International Meeting (18-22 Mayıs 2013) - New Orleans/ LA/ ABD
5. The Cost-of-Disease of Deep Venous Thrombosis and Its Short and Long-Term Clinical
Consequences in Turkey: An Expert Panel Approach for Estimation of Costs
ISPOR 18th Annual International Meeting (18-22 Mayıs 2013) - New Orleans/ LA/ ABD
6. The Cost–Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients with Atrial
Fibrillation (AF) in Turkey
ISPOR 18th Annual International Meeting (18-22 Mayıs 2013) - New Orleans/ LA/ ABD
7. The Cost–Effectiveness of Rivaroxaban Compared to Enoxaparin Plus Adjusted-Dose
Warfarin for the Treatment of Deep Venous Thrombosis (DVT) in Turkey
ISPOR 18th Annual International Meeting (18-22 Mayıs 2013) - New Orleans/ LA/ ABD
8. Whether The Treatment Expenditures or The Pharmaceutical Expenditures of Social
Security Institution (SSI) Have a Higher Increase Rate Between 2005 and 2011 in Turkey?
ISPOR 18th Annual International Meeting (18-22 Mayıs 2013) - New Orleans/ LA/ ABD
9. Comparison Retail Prices of Drug Prices Between Turkey and European Countries
ISPOR 16th Annual European Congress (2-6 Kasım 2013) - Dublin/ İRLANDA
10. Supplementary Health Insurance in Turkey
ISPOR 16th Annual European Congress (2-6 Kasım 2013) - Dublin/ İRLANDA
11. How Co-Payment Mechanism Has Changed Patients' Perception Towards OTC Type
Products?
ISPOR 16th Annual European Congress (2-6 Kasım 2013) - Dublin/ İRLANDA
12. Classification of Drugs Bringing From Abroad in Turkey According to Their ATC Codes
ISPOR 6th Asia Pacific Conference (6-9 Eylül 2014) - Beijing/ ÇİN
4
13. Development of HTA In Turkey
Research abstract for the ISPOR 17th Annual European Congress held in 8-12 November 2014
at Amsterdam/ HOLLANDA
14. Availability of Risk Sharing Agreements in the Turkish Pharmaceutical Sector
Research abstract for the ISPOR 17th Annual European Congress held in 8-12 November 2014
at Amsterdam/ HOLLANDA
15. Cost-Analysis of Chronic Idiopathic Urticaria Disease
Research abstract for the ISPOR 17th Annual European Congress held in 8-12 November 2014
at Amsterdam/ HOLLANDA
16. Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net
Tax Revenue for Turkey
Research abstract for the ISPOR 17th Annual European Congress held in 8-12 November 2014
at Amsterdam/ HOLLANDA
17. Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net
Tax Revenue: A Comparison in USA, Canada, Japan and Australia
Research abstract for the ISPOR 17th Annual European Congress held in 8-12 November 2014
at Amsterdam/ HOLLANDA
18. Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net
Tax Revenue: A Comparison in France, Germany, Italy, Spain, United Kingdom
Research abstract for the ISPOR 17th Annual European Congress held in 8-12 November 2014
at Amsterdam/ HOLLANDA
19. Value of Life And Cost of Pre-Mature Deaths With the Perspective of Productivity As Net
Tax Revenue: A Comparison in Argentina, Brazil and Mexico
Research abstract for the ISPOR 17th Annual European Congress held in 8-12 November 2014
at Amsterdam/ HOLLANDA
5